TEVA PHARMA - PRODUTOS FARMACEUTICOS, LDA secures contract for Call For Proposals Under Framework Agreement(S) 2023/304 - Group 4 Medicines: Blood; 2023/305 - Medicines For The Cardiovascular System; 2023/436 - Medications For The Systemic

Portugal, Oct. 10 -- Portugal based TEVA PHARMA - PRODUTOS FARMACEUTICOS, LDA has secured contract from Unidade Local Saude De Braga, E.P.E. for Call For Proposals Under Framework Agreement(S) 2023/304 - Group 4 Medicines: Blood; 2023/305 - Medicines For The Cardiovascular System; 2023/436 - Medications For The Systemic. The value of the contract is worth 344370 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....